Cargando…
The CDK1-Related lncRNA and CXCL8 Mediated Immune Resistance in Lung Adenocarcinoma
Background: Limited therapeutic options are available for advanced LUAD without driver gene mutations. Anti-CDK therapy has shown effectiveness in several kind of cancers, however, the mechanisms still need to be elucidated. Materials and Methods: The lncRNA associated with CDK1 and the immunomodula...
Autores principales: | Xue, Jinmin, Song, Yang, Xu, Wenwen, Zhu, Yuxi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454767/ https://www.ncbi.nlm.nih.gov/pubmed/36078096 http://dx.doi.org/10.3390/cells11172688 |
Ejemplares similares
-
Integrated Analysis of lncRNA–Mediated ceRNA Network in Lung Adenocarcinoma
por: Wu, Xianxian, et al.
Publicado: (2020) -
Identification and Validation of Immune-Related LncRNA Prognostic Signature for Lung Adenocarcinoma
por: Wu, Guomin, et al.
Publicado: (2021) -
Cuproptosis-related lncRNA predict prognosis and immune response of lung adenocarcinoma
por: Wang, Fangwei, et al.
Publicado: (2022) -
Novel lncRNA UPLA1 mediates tumorigenesis and prognosis in lung adenocarcinoma
por: Han, Xiaoyang, et al.
Publicado: (2020) -
LncRNA LINC01116 Contributes to Cisplatin Resistance in Lung Adenocarcinoma
por: Wang, Junbin, et al.
Publicado: (2020)